RxDoctor Payments Data

Cristen Kilpeck, PA

Physician Assistant · du Bois, PANPI 1548276355

Payments from drug & device makers

$403in general payments, 2019–2025

Across 22 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$121
  • AstraZeneca$95
  • Novo Nordisk$48
  • Johnson & Johnson$31
  • Pfizer$28
  • Axsome Therapeutics, Inc.$26
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$403100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$403 in reported general payments places this provider in the 60th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$29,946
Medicare patients
95
Services billed
443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole47$127,979
IngrezzaValbenazine Tosylate14$109,656
Invega SustennaPaliperidone Palmitate11$25,349
TrintellixVortioxetine Hydrobromide19$15,660
NuedextaDextromethorphan Hbr/Quinidine14$13,475
Lisdexamfetamine Dimesylate32$8,194
Quetiapine Fumarate374$7,371
Aripiprazole270$7,016
Chlorpromazine Hcl31$4,878
Oxcarbazepine120$4,850
Olanzapine218$4,755
Buspirone Hcl231$3,774
Trazodone Hcl322$3,695
Quetiapine Fumarate ErQuetiapine Fumarate53$3,618
Duloxetine Hcl199$3,603

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$121$127,97947 claims
Johnson & JohnsonInvega Sustenna$31$25,34911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in du Bois

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →